RELA, RELA proto-oncogene, NF-kB subunit, 5970

N. diseases: 483; N. variants: 11
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0014474
Disease: Ependymoma
Ependymoma
0.500 Biomarker disease HPO
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.450 Biomarker group HPO
CUI: C0023903
Disease: Liver neoplasms
Liver neoplasms
0.130 Biomarker group HPO
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.130 Biomarker disease HPO
CUI: C0024121
Disease: Lung Neoplasms
Lung Neoplasms
0.110 Biomarker group HPO
CUI: C0030193
Disease: Pain
Pain
0.110 Biomarker phenotype HPO
CUI: C0036572
Disease: Seizures
Seizures
0.110 Biomarker phenotype HPO
CUI: C0037930
Disease: Spinal Cord Neoplasms
Spinal Cord Neoplasms
0.100 Biomarker group HPO
CUI: C0038874
Disease: Supratentorial Neoplasms
Supratentorial Neoplasms
0.100 Biomarker group HPO
CUI: C0042963
Disease: Vomiting
Vomiting
0.100 Biomarker phenotype HPO
CUI: C0149745
Disease: Oral Ulcer
Oral Ulcer
0.100 Biomarker disease HPO
CUI: C0149931
Disease: Migraine Disorders
Migraine Disorders
0.100 Biomarker group HPO
CUI: C0392699
Disease: Dysesthesia
Dysesthesia
0.100 Biomarker phenotype HPO
CUI: C0427065
Disease: Distal muscle weakness
Distal muscle weakness
0.100 Biomarker phenotype HPO
CUI: C0575081
Disease: Gait abnormality
Gait abnormality
0.100 Biomarker group HPO
CUI: C4476793
Disease: Abnormal cell morphology
Abnormal cell morphology
0.100 Biomarker phenotype HPO
CUI: C4551915
Disease: Gait Disturbance, CTCAE
Gait Disturbance, CTCAE
0.100 Biomarker phenotype HPO
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 Biomarker group BEFREE Expression of the p65 delta cDNA in Rat-1 fibroblasts resulted in focus formation, anchorage-independent growth in soft agar, and tumor formation in athymic nude mice, effects not obtained with expression of p65 or a p65 delta mutant that contains a disruption within the transcriptional activation domain. 1566083 1992
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 Biomarker group BEFREE Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression. 8234333 1993
CUI: C0016057
Disease: Fibrosarcoma
Fibrosarcoma
0.010 AlteredExpression disease BEFREE Stable transfectants of a fibrosarcoma cell line expressing dexamethasone-inducible antisense RNA to p65 showed inhibition of in vitro growth and in vivo tumor development. 8234333 1993
CUI: C0030779
Disease: Pelger-Huet Anomaly
Pelger-Huet Anomaly
0.010 Biomarker disease BEFREE Phorbol ester (PMA) and phytohemagglutinin (PHA) treatment of Jurkat cells did not activate the p65 promoter in transient transfection experiments. 8450395 1993
CUI: C0278595
Disease: Adult Fibrosarcoma
Adult Fibrosarcoma
0.010 AlteredExpression disease BEFREE Stable transfectants of a fibrosarcoma cell line expressing dexamethasone-inducible antisense RNA to p65 showed inhibition of in vitro growth and in vivo tumor development. 8234333 1993
CUI: C0009319
Disease: Colitis
Colitis
0.550 Biomarker disease BEFREE Local administration of p65 antisense phosphorothioate oligonucleotides abrogated clinical and histological signs of colitis and was more effective in treating TNBS-induced colitis than single or daily administration of glucocorticoids. 8782457 1996
CUI: C0010346
Disease: Crohn Disease
Crohn Disease
0.030 Biomarker disease BEFREE The data provide direct evidence for the central importance of p65 in chronic intestinal inflammation and suggest a potential therapeutic utility of p65 antisense oligonucleotides as a novel molecular approach for the treatment of patients with Crohn's disease. 8782457 1996
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 GeneticVariation group BEFREE Identification of a tumor-associated mutant form of the NF-kappaB RelA gene with reduced DNA-binding and transactivating activities. 9047386 1997